Literature DB >> 2550307

Hepatitis B virus infection in liver cirrhosis and hepatocellular carcinoma in Jakarta Indonesia.

H A Sulaiman1.   

Abstract

The relationship between hepatitis B virus (HBV) infection and 144 cases with liver cirrhosis (LC) and 82 cases with hepatocellular carcinoma (HCC), admitted to the Department of Internal Medicine, Dr. Cipto Mangunkusmo Hospital in Jakarta, was investigated within the period from January 1 until December 31, 1984. The prevalence of HBsAg in 144 cases with LC was 41.1%, anti-HBs 33.3% and anti-HBc alone 16.0%. In only 9.0% no markers were found. The prevalence of HBeAg in 60 cases HBsAg positive LC was 35.0%, anti-HBe was 41.7% and in 23.3% both markers were negative. Among 82 cases with HCC, the prevalence of HBsAg was 47.6%, anti-HBs was 25.6% and anti-HBc alone was 15.9%. The prevalence of HBeAg in 39 cases with HCC was 25.6%, anti-HBe was 51.3% and in 23.1% both markers were negative. Age distribution between HBsAg positive and negative in LC was observed significant difference (P less than 0.05). Mean age of HBsAg positive group in LC was 5 years younger than that of the HBsAg negative group.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550307     DOI: 10.1007/BF02774353

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  13 in total

Review 1.  Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.

Authors:  W Szmuness
Journal:  Prog Med Virol       Date:  1978

2.  Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.

Authors:  M Omata; M Ashcavai; C T Liew; R L Peters
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

3.  Hepatitis-associated antigen in hepatocellular carcinoma in Taiwan.

Authors:  J L Sung; T Sekine; T M Lin; K Nishioka; M Mayumi; Y F Liao; C H Liu
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1972-07-28

4.  Hepatitis-associated antigen in chronic liver disease.

Authors:  S J Hadziyannis; G E Merikas; A P Afroudakis
Journal:  Lancet       Date:  1970-07-11       Impact factor: 79.321

5.  Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observations in 31 patients.

Authors:  Y Kubo; K Okuda; H Musha; T Nakashima
Journal:  Gastroenterology       Date:  1978-03       Impact factor: 22.682

Review 6.  Relationship between hepatocellular carcinoma and cirrhosis.

Authors:  M C Kew; H Popper
Journal:  Semin Liver Dis       Date:  1984-05       Impact factor: 6.115

7.  Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.

Authors:  D S Chen; J L Sung; M Y Lai
Journal:  Hepatogastroenterology       Date:  1981-12

8.  Hepatitis B and primary hepatocellular carcinoma in a European population.

Authors:  D Trichopoulos; E Tabor; R J Gerety; E Xirouchaki; L Sparros; N Munoz; C A Linsell
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

9.  Androgen-induced hepatoma.

Authors:  G C Farrell; D E Joshua; R F Uren; P J Baird; K W Perkins; H Kronenberg
Journal:  Lancet       Date:  1975-02-22       Impact factor: 79.321

10.  Association of hepatitis B virus infection with hepatocellular carcinoma in American patients.

Authors:  R L Yarrish; B G Werner; B S Blumberg
Journal:  Int J Cancer       Date:  1980-12-15       Impact factor: 7.396

View more
  2 in total

Review 1.  Hepatitis B virus infection in Indonesia.

Authors:  Yoshihiko Yano; Takako Utsumi; Maria Inge Lusida; Yoshitake Hayashi
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

2.  The effect of propranolol in malay patients with liver cirrhosis - a pharmacodynamic evaluation.

Authors:  R Zain-Hamid; Z Ismail; S Mahendra Raj; I L Shuaib; S S J Mohsin
Journal:  Malays J Med Sci       Date:  2003-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.